Thats why its important to understand the potential risks of GLP-1 medications and how they can affect your body over time
No product or service offered by the Company through its Website is intended to offer any medical advice, suggestion, diagnosis, cure, or relief for any medical issue whatsoever and is sold on the single premise of research only
Phase 2 trial results, published in 2023 in the New England Journal of Medicine (Jastreboff et al., NEJM 2023), demonstrated that participants receiving the highest dose of retatrutide lost an average of approximately 24% of their body weight over 48 weeks a finding that attracted considerable attention from the medical and scientific communities
Increasing Awareness of GLP-1 Therapies Awareness of GLP-1 receptor agonists as effective treatment options for diabetes is steadily increasing in India
Unlike many general probiotic formulas, Pendulum GLP-1 Probiotic Pro focuses on strains associated with metabolic health pathways
Despite the limitations of real-world observational studiesincluding the absence of randomization, control for confounding variables, and inability to establish causalityresearches offer confidence regarding the pancreatic safety profiles of GLP-1 RAs [55,61]
:max_bytes(150000):strip_icc()/health-GettyImages-2025836701-ce3f5ccf0f98428e9d14abaeb07ba307.jpg)
